An Israeli tropical-disease expert says he has new proof that a drug used to fight parasites in third-world countries could help reduce the length of infection for people who contract coronavirus. Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba Medical Center in Tel Hashomer, last week completed a clinical trial of the US Food and Drug Administration-approved drug ivermectin, a broad-spectrum antiparasitic agent that has also been shown to fight viruses.
Sheba researcher: Antiparasitic drug reduces length of COVID-19 infection | | | | | | | | | | | Sheba researcher: Antiparasitic drug reduces length of COVID-19 infection According to his yet to be published data, Schwartz said that the drug was shown to help “cure” people of the vi... | | |
